NPCE
#2943
Neuropace, Inc. - Common Stock
14.1 3 USD
+0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.67%
Monthly Change
-3.22%
6 month change
-0.49%
Year Change
+33.55%
Previous Close
14.6 8
Open
14.1 3
Low
14.1 3
High
14.1 3
Volume
24
Financials
- Market Capitalization 485 M
- Employee 220
- Founded 1997
- CEO N/A
- Website www.neuropace.com
- Headquarter Delaware, United States
- FIGI BBG001KWZD52
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-23.39
Price to sales ratio
5.05
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2896 |  TCMD Tactile Systems Technology, Inc. - Common Stock | 22.79 USD | -1.38% | -2.48% | -17.31% | +72.26% | 516.25 M USD | ||
| 2927 |  SENS Senseonics Holdings, Inc. - Common Stock | 9.34 USD | -0.64% | -1.48% | +89.45% | +18.53% | 493.84 M USD | ||
| 2961 |  CLPT ClearPoint Neuro Inc. - Common Stock | 15.57 USD | -2.32% | +0.91% | +8.05% | +48.43% | 474.95 M USD | ||
| 2965 |  PACB Pacific Biosciences of California, Inc. - Common Stock | 1.43 USD | -7.74% | +10.85% | +3.62% | +7.52% | 444.49 M USD |
Frequently asked questions about Neuropace, Inc. Common Stock
What is the Neuropace, Inc. Common Stock stock price today?
The current price of Neuropace, Inc. Common Stock (NPCE) is 14.13. Over the past 24 hours, the stock has changed by +3.67%. Follow the NPCE chart for real-time price dynamics.
What is the stock ticker of Neuropace, Inc. Common Stock?
Neuropace, Inc. Common Stock trades under the ticker NPCE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neuropace, Inc. Common Stock stock going up?
NPCE has changed by -0.21% over the last week, -3.22% over the last month, and +33.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Neuropace, Inc. Common Stock?
Neuropace, Inc. Common Stock currently has a market capitalization of 485 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Neuropace, Inc. Common Stock earnings last quarter?
Last quarter, Neuropace, Inc. Common Stock reported earnings of -0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Neuropace, Inc. Common Stock revenue for the last quarter?
Neuropace, Inc. Common Stock reported quarterly revenue of 22.83 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Neuropace, Inc. Common Stock net income for the last quarter?
Neuropace, Inc. Common Stock reported net income of -6.2 M for the last quarter. The previous quarter showed -6.69 M, which means net income changed by +7.31%.
Is Neuropace, Inc. Common Stock a good dividend stock?
Neuropace, Inc. Common Stock currently has a dividend yield of 0%. Previously, the dividend yield was 0%, compared with 0% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Neuropace, Inc. Common Stock have?
As of the latest available data, Neuropace, Inc. Common Stock has 220 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neuropace, Inc. Common Stock EBITDA?
Neuropace, Inc. Common Stock EBITDA is -4.97 M, and its EBITDA margin is -21.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neuropace, Inc. Common Stock stock?
You can buy Neuropace, Inc. Common Stock (NPCE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neuropace, Inc. Common Stock stock?
Investing in Neuropace, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NPCE chart and related analysis on metatrader.com as part of your research.